Apigenin ameliorates hyperuricemic nephropathy by inhibiting URAT1 and GLUT9 and relieving renal fibrosis via the Wnt/β-catenin pathway.

MLA

Li, Yongmei, et al. “Apigenin Ameliorates Hyperuricemic Nephropathy by Inhibiting URAT1 and GLUT9 and Relieving Renal Fibrosis via the Wnt/β-Catenin Pathway.” Phytomedicine : International Journal of Phytotherapy and Phytopharmacology, vol. 87, July 2021, p. 153585. EBSCOhost, https://doi.org/10.1016/j.phymed.2021.153585.

APA

Li, Y., Zhao, Z., Luo, J., Jiang, Y., Li, L., Chen, Y., Zhang, L., Huang, Q., Cao, Y., Zhou, P., Wu, T., & Pang, J. (2021). Apigenin ameliorates hyperuricemic nephropathy by inhibiting URAT1 and GLUT9 and relieving renal fibrosis via the Wnt/β-catenin pathway. Phytomedicine : International Journal of Phytotherapy and Phytopharmacology, 87, 153585. https://doi.org/10.1016/j.phymed.2021.153585

Chicago

Li, Yongmei, Zean Zhao, Jian Luo, Yanqing Jiang, Lu Li, Yanyu Chen, Leqi Zhang, et al. 2021. “Apigenin Ameliorates Hyperuricemic Nephropathy by Inhibiting URAT1 and GLUT9 and Relieving Renal Fibrosis via the Wnt/β-Catenin Pathway.” Phytomedicine : International Journal of Phytotherapy and Phytopharmacology 87 (July): 153585. doi:10.1016/j.phymed.2021.153585.